Brief: Corvus Pharmaceuticals Announces Publication Of Biochemistry And Preclinical Data
04/12/2024 21:28
Dec 4 (Reuters) - Corvus Pharmaceuticals Inc CRVS.O :
* CORVUS PHARMACEUTICALS ANNOUNCES PUBLICATION OF
BIOCHEMISTRY AND
PRECLINICAL DATA DEMONSTRATING POTENTIAL OF ITK INHIBITION WITH
SOQUELITINIB AS A NOVEL APPROACH TO MODULATE TUMOR IMMUNITY
Source text: ID:nGNX3NdBzd
Further company coverage: CRVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corvus Pharmaceuticals
See all newsBrief: Corvus Pharmaceuticals Announces Initiation Of Phase 1B Clinical Trial Of Soquelitinib For Patients With Hidradenitis Suppurativa
Corvus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental